75 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
, a novel and proprietary state-of-the-art delivery system for pegfilgrastim-cbqv, was launched in February 2024. High customer demand and confirmed
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
, a novel and proprietary state-of-the-art delivery system for pegfilgrastim-cbqv, was launched in February 2024. High customer demand coupled
8-K
EX-2.1
iqs2v3oj
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
4l1 9zhf8wyqsmsl
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
425
j5r9q jley
16 Jun 23
Business combination disclosure
8:08am
425
rgjftgf777a u1i
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
emhwds 0xxk5il0827q
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
spr1fe5m92yohpg5q
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am